These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 26766744)

  • 1. Drug crystallization - implications for topical and transdermal delivery.
    Hadgraft J; Lane ME
    Expert Opin Drug Deliv; 2016 Jun; 13(6):817-30. PubMed ID: 26766744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation issues associated with transdermal fentanyl delivery.
    Santos P; Watkinson AC; Hadgraft J; Lane ME
    Int J Pharm; 2011 Sep; 416(1):155-9. PubMed ID: 21723931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation design and development of matrix diffusion controlled transdermal drug delivery of glimepiride.
    Akram MR; Ahmad M; Abrar A; Sarfraz RM; Mahmood A
    Drug Des Devel Ther; 2018; 12():349-364. PubMed ID: 29503528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural oils as skin permeation enhancers for transdermal delivery of olanzapine: in vitro and in vivo evaluation.
    Aggarwal G; Dhawan S; HariKumar SL
    Curr Drug Deliv; 2012 Mar; 9(2):172-81. PubMed ID: 22023211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation optimization of a drug in adhesive transdermal analgesic patch.
    Ravula R; Herwadkar AK; Abla MJ; Little J; Banga AK
    Drug Dev Ind Pharm; 2016; 42(6):862-70. PubMed ID: 26288995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
    Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
    Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
    Rastogi V; Yadav P; Husain A; Verma A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spray-on transdermal drug delivery systems.
    Ibrahim SA
    Expert Opin Drug Deliv; 2015 Feb; 12(2):195-205. PubMed ID: 25227233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Pharmacokinetics of Transdermal Scopolamine: Measurements and Modeling.
    Pensado A; Hattam L; White KAJ; McGrogan A; Bunge AL; Guy RH; Delgado-Charro MB
    Mol Pharm; 2021 Jul; 18(7):2714-2723. PubMed ID: 34124907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle formulations as recrystallization inhibitors in transdermal patches.
    Tahir MA; Ali ME; Lamprecht A
    Int J Pharm; 2020 Feb; 575():118886. PubMed ID: 31790804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
    Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
    Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical delivery of hexamidine.
    Parisi N; Paz-Alvarez M; Matts PJ; Lever R; Hadgraft J; Lane ME
    Int J Pharm; 2016 Jun; 506(1-2):332-9. PubMed ID: 27130367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of backing films on the transdermal delivery of donepezil from patches.
    Liu N; Zhang Y; Cun D; Quan P; Fang L
    AAPS PharmSciTech; 2014 Dec; 15(6):1569-73. PubMed ID: 25134467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of antihistaminic transdermal films based on alginate-chitosan polyelectrolyte complexes: characterization and permeation studies.
    Lefnaoui S; Moulai-Mostefa N; Yahoum MM; Gasmi SN
    Drug Dev Ind Pharm; 2018 Mar; 44(3):432-443. PubMed ID: 29098871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the in vitro permeation of ibuprofen in mammalian skin, the PAMPA model and silicone membrane.
    Luo L; Patel A; Sinko B; Bell M; Wibawa J; Hadgraft J; Lane ME
    Int J Pharm; 2016 May; 505(1-2):14-9. PubMed ID: 27025294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microstructured bicontinuous phase formulations: their characterization and application in dermal and transdermal drug delivery.
    Lapteva M; Kalia YN
    Expert Opin Drug Deliv; 2013 Aug; 10(8):1043-59. PubMed ID: 23600804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric and lipid-based materials for topical nanoparticle delivery systems.
    Pawar KR; Babu RJ
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):419-59. PubMed ID: 21083529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
    Ahmed TA; El-Say KM
    Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.